Literature DB >> 24183035

[Usefulness of ultrasonography in the differential diagnosis of thyroidal follicular tumor].

Xing-jian Lai1, Bo Zhang, Yu-xin Jiang, Qing-li Zhu, Meng Yang, Qing Dai, Yu Xia, Xiao Yang, Rui-na Zhao.   

Abstract

OBJECTIVE: To evaluate the usefulness of ultrasonography in distinguishing follicular carcinoma from adenoma.
METHODS: The ultrasound data of 37 patients with histopathologically confirmed follicular carcinomas who were treated in PUMC Hospital from January 2000 to November 2012 were retrospectively studied. In addition, 74 sex-and age-matched patients with histopathologically confirmed adenomas during the same period were enrolled as the control group. The pathologic results were regarded as the gold standard.
RESULTS: Irregular shape (32.4% of follicular carcinoma vs 5.4% of adenoma), absence of thin halo (67.6% vs 36.5%), indistinct margin (21.6% vs 1.4%), hypoechoic appearance (64.9% vs 39.2%), punctuate calcification(40.5% vs 13.5%), absence of cystic change (78.4% vs 54.1%), and being complicated with other thyroid disease (56.8% vs 28.4%) were more frequently associated with follicular carcinoma than with benign adenoma (P<0.05). No significant difference in the echotexture and internal flow was observed between the two groups (P>0.05).
CONCLUSION: Although follicular carcinoma and adenoma share many sonographic features, irregular shape, absence of thin halo, indistinct margin, hypoechoic appearance, punctuate calcification, absence of cystic change, and being complicated with other thyroid disease favor a follicular carcinoma diagnosis.

Entities:  

Mesh:

Year:  2013        PMID: 24183035     DOI: 10.3881/j.issn.1000-503X.2013.05.002

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  1 in total

1.  One case of papillary thyroid carcinoma complicated with epidermal follicular carcinoma was followed up for four years.

Authors:  Wei Yan; Qing-Jun Gao; Rong-Jun Gao; Yan Zhou; Wei Zhang; Wen-Li Tang; Hui Ye
Journal:  Arch Med Sci       Date:  2022-02-24       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.